Skip to Main Content

Author Details

Daniel J Serie
Mayo Clinic
2010
75
30
PMIDPaper TitleJournal TitlePublished Year
37388743Plasma glycoproteomic biomarkers identify metastatic melanoma patients with reduced clinical benefit from immune checkpoint inhibitor therapy.Front Immunol2023
35336960Differential Peripheral Blood Glycoprotein Profiles in Symptomatic and Asymptomatic COVID-19.Viruses2022
35610260Adaptive immune signature in HER2-positive breast cancer in NCCTG (Alliance) N9831 and NeoALTTO trials.NPJ Breast Cancer2022
35286803Serum Glycoprotein Markers in Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma.J Proteome Res2022
35148948Novel plasma glycoprotein biomarkers predict progression-free survival in surgically resected clear cell renal cell carcinoma.Urol Oncol2022
33635380Latent trait modeling of tau neuropathology in progressive supranuclear palsy.Acta Neuropathol2021
33875655Transcriptomic analysis to identify genes associated with selective hippocampal vulnerability in Alzheimer's disease.Nat Commun2021
32416316PB-Net: Automatic peak integration by sequential deep learning for multiple reaction monitoring.J Proteomics2020
31829518Concordance of PD-1 and PD-L1 (B7-H1) in paired primary and metastatic clear cell renal cell carcinoma.Cancer Med2020
33241186Validation of the NSABP/NRG Oncology 8-Gene Trastuzumab-benefit Signature in Alliance/NCCTG N9831.JNCI Cancer Spectr2020
331214618q24 clear cell renal cell carcinoma germline variant is associated with VHL mutation status and clinical aggressiveness.BMC Urol2020
32903434Association of Genetic Variants at <i>TRPC6</i> With Chemotherapy-Related Heart Failure.Front Cardiovasc Med2020
30882205Site-Specific Glycosylation Quantitation of 50 Serum Glycoproteins Enhanced by Predictive Glycopeptidomics for Improved Disease Biomarker Discovery.Anal Chem2019
31622131Incidence of Late Relapses in Patients With HER2-Positive Breast Cancer Receiving Adjuvant Trastuzumab: Combined Analysis of NCCTG N9831 (Alliance) and NRG Oncology/NSABP B-31.J Clin Oncol2019
30808774Effects of Age and Immune Landscape on Outcome in HER2-Positive Breast Cancer in the NCCTG N9831 (Alliance) and NSABP B-31 (NRG) Trials.Clin Cancer Res2019
29023769Alcohol consumption, variability in alcohol dehydrogenase genes and risk of renal cell carcinoma.Int J Cancer2018
29986742Replication of progressive supranuclear palsy genome-wide association study identifies SLCO1A2 and DUSP10 as new susceptibility loci.Mol Neurodegener2018
30005627Chromoanasynthesis is a common mechanism that leads to ERBB2 amplifications in a cohort of early stage HER2<sup>+</sup> breast cancer samples.BMC Cancer2018
30136084Divergent brain gene expression patterns associate with distinct cell-specific tau neuropathology traits in progressive supranuclear palsy.Acta Neuropathol2018
29724592Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study.Lancet Neurol2018
29737278Determining the genetic basis of anthracycline-cardiotoxicity by molecular response QTL mapping in induced cardiomyocytes.Elife2018
29623256Association Between Programmed Death-Ligand 1 Expression and the Vascular Endothelial Growth Factor Pathway in Angiosarcoma.Front Oncol2018
29107053Conserved brain myelination networks are altered in Alzheimer's and other neurodegenerative diseases.Alzheimers Dement2018
27939925A candidate regulatory variant at the TREM gene cluster associates with decreased Alzheimer's disease risk and increased TREML1 and TREM2 brain gene expression.Alzheimers Dement2017
28480329African American exome sequencing identifies potential risk variants at Alzheimer disease loci.Neurol Genet2017
28101782The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC-derived cardiomyocytes.Clin Transl Med2017
28327121BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: tumor heterogeneity and concordance with paired primary tumor.BMC Urol2017
28242297Systems biology approach to late-onset Alzheimer's disease genome-wide association study identifies novel candidate genes validated using brain expression data and Caenorhabditis elegans experiments.Alzheimers Dement2017
29367538Breast Cancer Clinical Trial of Chemotherapy and Trastuzumab: Potential Tool to Identify Cardiac Modifying Variants of Dilated Cardiomyopathy.J Cardiovasc Dev Dis2017
28976794Multicenter Validation of Enhancer of Zeste Homolog 2 Expression as an Independent Prognostic Marker in Localized Clear Cell Renal Cell Carcinoma.J Clin Oncol2017
28647866Coffee consumption and risk of renal cell carcinoma.Cancer Causes Control2017
28763429Genome-wide association study of cardiotoxicity in the NCCTG N9831 (Alliance) adjuvant trastuzumab trial.Pharmacogenet Genomics2017
27899233Clear Cell Type A and B Molecular Subtypes in Metastatic Clear Cell Renal Cell Carcinoma: Tumor Heterogeneity and Aggressiveness.Eur Urol2017
27993815Differential gene expression profiling of matched primary renal cell carcinoma and metastases reveals upregulation of extracellular matrix genes.Ann Oncol2017
26723183Mayo Adhesive Probability Score Is Associated With Localized Renal Cell Carcinoma Progression-free Survival.Urology2016
28723492Validation of Gene Expression Signatures to Identify Low-risk Clear-cell Renal Cell Carcinoma Patients at Higher Risk for Disease-related Death.Eur Urol Focus2016
26516698Loss of histone H3 lysine 36 trimethylation is associated with an increased risk of renal cell carcinoma-specific death.Mod Pathol2016
26627941Association of Parkinson disease age of onset with DRD2, DRD3 and GRIN2B polymorphisms.Parkinsonism Relat Disord2016
26300218Clear Cell Renal Cell Carcinoma Subtypes Identified by BAP1 and PBRM1 Expression.J Urol2016
27587788A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci.Cancer Epidemiol Biomarkers Prev2016
27727239Human whole genome genotype and transcriptome data for Alzheimer's and other neurodegenerative diseases.Sci Data2016
27863434A microRNA biomarker panel for the non-invasive detection of bladder cancer.Oncotarget2016
27231851Urinary mRNA biomarker panel for the detection of urothelial carcinoma.Oncotarget2016
27115769Gene expression, methylation and neuropathology correlations at progressive supranuclear palsy risk loci.Acta Neuropathol2016
26797576Author Reply.Urology2016
27078887Assessment of Tumor Heterogeneity, as Evidenced by Gene Expression Profiles, Pathway Activation, and Gene Copy Number, in Patients with Multifocal Invasive Lobular Breast Tumors.PLoS One2016
25175426Assessing the clinical use of clear cell renal cell carcinoma molecular subtypes identified by RNA expression analysis.Urol Oncol2015
26648255Corrigendum: Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients.Nat Commun2015
27066552Late-onset Alzheimer disease risk variants mark brain regulatory loci.Neurol Genet2015
26077951Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy.Nat Commun2015
  • 1 - 50 of 75

Recommended Authors

Kuan-Lin Huang
Icahn School of Medicine at Mount Sinai
Career Start Year 2013
Number of shared co-authors 5
Arshi Arora
Memorial Sloan Kettering Cancer Center
Career Start Year 2011
Number of shared co-authors 0
Guanglong Jiang
Indiana University School of Medicine
Career Start Year 2011
Number of shared co-authors 0
Wenyi Wang
The University of Texas MD Anderson Cancer Center
Career Start Year 2010
Number of shared co-authors 0
Ganiraju C Manyam
the University of Texas MD Anderson Cancer Center
Career Start Year 2009
Number of shared co-authors 1
Karolina Edlund
Leibniz Research Centre for Working Environment and Human Factors at TU Dortmund
Career Start Year 2008
Number of shared co-authors 0
Qiyuan Li
National Institute of Data Science in Health and Medicine, Xiamen University
Career Start Year 2008
Number of shared co-authors 29
Yang Xie
Quantitative Biomedical Research Center
Career Start Year 2007
Number of shared co-authors 2
Eric C Polley
Mayo Clinic
Career Start Year 2007
Number of shared co-authors 14
Pichai Raman
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year 2006
Number of shared co-authors 1
Svitlana Tyekucheva
Dana-Farber Cancer Institute
Career Start Year 2006
Number of shared co-authors 2
Kouros Owzar
Duke University
Career Start Year 2005
Number of shared co-authors 16
Benjamin Haibe-Kains
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2004
Number of shared co-authors 2
Obi L Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 3
Syed Haider
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 7
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 9
Michael Slifker
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Keyue Ding
Queen's University
Career Start Year 2002
Number of shared co-authors 1
Olivier Elemento
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 1
Habib Hamidi
Genentech Inc.
Career Start Year 2002
Number of shared co-authors 11
Vladimir Makarov
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 1
Lodewyk F A Wessels
University Medical Centre Mannheim, University of Heidelberg
Career Start Year 2000
Number of shared co-authors 10
Andrea Sboner
Institute for Computational Biomedicine
Career Start Year 2000
Number of shared co-authors 2
Celine Lefebvre
The Scripps Research Institute
Career Start Year 1999
Number of shared co-authors 0
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 0
Sudhir Varma
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 6
Adam B Olshen
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 1
Keith A Baggerly
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 2
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 1
Paul C Boutros
University of California los angeles
Career Start Year 1970
Number of shared co-authors 16

Collaborators

Richard W Joseph
Mayo Clinic Hospital
Co-authored papers 16
Yan W Asmann
Mayo Clinic
Co-authored papers 14
Julia E Crook
Center for Clinical and Translational Science, Mayo Clinic
Co-authored papers 13
Thai H Ho
Mayo Clinic Arizona
Co-authored papers 13
Nil??fer Ertekin-Taner
Mayo Clinic
Co-authored papers 13
Dennis W Dickson
Mayo Clinic Jacksonville
Co-authored papers 12
Neill R Graff-Radford
Mayo Clinic Florida
Co-authored papers 11
Xue Wang
Mayo Clinic
Co-authored papers 11
Mariet Allen
Mayo Clinic
Co-authored papers 11
Minerva M Carrasquillo
Mayo Clinic
Co-authored papers 10
Steven G Younkin
Mayo Clinic
Co-authored papers 9
Jeremy D Burgess
Mayo Clinic
Co-authored papers 8
Thuy Nguyen
Mayo Clinic
Co-authored papers 8
Curtis S Younkin
Mayo Clinic
Co-authored papers 7
Ronald C Petersen
Mayo Clinic Rochester
Co-authored papers 7
Kimberly G Malphrus
Mayo Clinic Florida
Co-authored papers 7
Sarah J Lincoln
Mayo Clinic
Co-authored papers 6
Nathan D Price
Institute for Systems Biology
Co-authored papers 5
Chen Wang
Center for Individualized Medicine, Mayo Clinic
Co-authored papers 5
Todd E Golde
Emory Center for Neurodegenerative Disease
Co-authored papers 5
Gerard D Schellenberg
Co-authored papers 4
Brooke L Fridley
H. Lee Moffitt Cancer Center and Research Institute
Co-authored papers 4
Rosa Rademakers
University of Antwerp
Co-authored papers 4
Sundararajan Vincent Rajkumar
Co-authored papers 4
Shannon K McDonnell
Mayo Clinic
Co-authored papers 4
Ellen L Goode
Mayo Clinic College of Medicine
Co-authored papers 4
Cory C Funk
Institute for Systems Biology
Co-authored papers 3
Brian M Bot
Co-authored papers 3
NiCole A Finch
Mayo Clinic
Co-authored papers 3
Robert B Diasio
Mayo Clinic
Co-authored papers 3
Release 1.2